GlobeImmune Inc. announced that Timothy C. Rodell has resigned his positions as the company's Chief Executive Officer and President but remains on the Board of Directors; C. Jeffrey Dekker has been appointed as the company's President, Secretary and Treasurer and been named to the company's Board of Directors; J. William Freytag, Augustine J. Lawlor, Dan J. Mitchell and S. Edward Torres have resigned from the company's Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5 | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.30% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- GBIM Stock
- News GlobeImmune, Inc.
- GlobeImmune Inc. Announces Management and Board Changes